KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Exchange Rate Effect: 2014-2024

Historic Exchange Rate Effect for Palvella Therapeutics (PVLA) over the last 10 years, with Dec 2024 value amounting to $3,000.

  • Palvella Therapeutics' Exchange Rate Effect rose 104.00% to $3,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$197,000, marking a year-over-year change of. This contributed to the annual value of $3,000 for FY2024, which is N/A change from last year.
  • Per Palvella Therapeutics' latest filing, its Exchange Rate Effect stood at $3,000 for Q4 2024, which was up 104.00% from -$75,000 recorded in Q4 2023.
  • In the past 5 years, Palvella Therapeutics' Exchange Rate Effect ranged from a high of $2.2 million in Q3 2020 and a low of -$3.3 million during Q2 2022.
  • Over the past 3 years, Palvella Therapeutics' median Exchange Rate Effect value was -$75,000 (recorded in 2023), while the average stood at -$574,667.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first spiked by 515.81% in 2020, then plummeted by 10,268.75% in 2022.
  • Quarterly analysis of 5 years shows Palvella Therapeutics' Exchange Rate Effect stood at $2.0 million in 2020, then plummeted by 144.33% to -$903,000 in 2021, then surged by 315.39% to $1.9 million in 2022, then plummeted by 103.86% to -$75,000 in 2023, then surged by 104.00% to $3,000 in 2024.
  • Its last three reported values are $3,000 in Q4 2024, -$75,000 for Q4 2023, and -$337,000 during Q3 2023.